- Presentations
- 6
- Markets
- 1
Prograf is a brand of Tacrolimus marketed by Astellas Pharma, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Tacrolimus
- Brand owner
- Astellas Pharma
- Registered in
- United States
- Strengths and forms
- 0.5 mg capsule, 1 mg capsule, 5 mg capsule, 5 mg/1 mL injection, 0.2 mg oral suspension, 1 mg oral suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Prograf 0.5 mg capsuleOral | Astellas Pharma | US FDA | Available on request |
| Prograf 1 mg capsuleOral | Astellas Pharma | US FDA | Available on request |
| Prograf 5 mg capsuleOral | Astellas Pharma | US FDA | Available on request |
| Prograf 5 mg/1 mL injectionIntravenous | Astellas Pharma | US FDA | Available on request |
| Prograf 0.2 mg oral suspensionOral | Astellas Pharma | US FDA | Available on request |
| Prograf 1 mg oral suspensionOral | Astellas Pharma | US FDA | Available on request |
Equivalent brands
Other brands of Tacrolimus.
Brand names and trademarks belong to their owners and are used only to identify products.
Request Prograf
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.